Agfa-Gevaert: Michel Govaert Resigns from the Board of Directors
Agfa-Gevaert announces the departure of Michel Govaert from the board of directors. The resignation of the independent member is effective immediately due to personal reasons.
Michel Govaert, serving as the permanent representative of MJP Management Services BV, has tendered his resignation as an independent member of the Agfa-Gevaert board of directors. The resignation takes effect from Wednesday, May 20, 2026. The board of directors expressed their gratitude towards Michel Govaert for his contributions and expertise during his tenure in the governance body.
Succession Procedure Initiated
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The Nomination and Remuneration Committee will soon initiate the procedure to fill the position.
SectorDispositifs médicaux et optique›Dispositifs médicaux / imagerie
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 512 millions d'euros
Quarterly revenue: 512 millions d'euros
Revenue growth: -2,2 %
EBITDA: 25 millions d'euros
EBITDA margin: 4,9 %
Net income: -27 millions d'euros
Free cash flow: -52 millions d'euros
127 millions d'euros
Guidance from the release
The full year 2026 free cash flow is expected to be more negative than in 2025
Risks mentioned
Flux de trésorerie disponible négatif de 52 M€ au S1 2026, aggravé par les coûts de transformation et de réorganisation
Faiblesse persistante du marché Green Hydrogen Solutions liée aux retards de mise en œuvre de la directive RED III
Baisse du chiffre d'affaires de HealthCare IT de 7,3% hors effet de change liée à la transition cloud
Opportunities identified
EBITDA ajusté du groupe en hausse de 66% au S1 2026 grâce aux programmes d'économies
Recettes récurrentes de HealthCare IT en hausse de 4% hors effet de change au T2 2026, où elles représentent 66% du chiffre d'affaires du segment
Amélioration du fonds de roulement dans toutes les activités hors film grâce à un programme d'affacturage avec BNP Paribas Fortis
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.